Skip to main content

Publications

FY2019

  • Quast ABE, Baalman SWE, Brouwer TF, Smeding L, Wilde AAM, Burke MC, Knops RE. A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable defibrillator: The PRAETORIAN score. Heart Rhythm 2019; 16(3): 403-410. 
  • Rajamannan NM. TIEG1 is upregulated in Lrp5/6-mediated valve osteogenesis. J Cell Biochem. 2018 Sep 23. doi: 10.1002/jcb.27606.
  • Essandoh MK, Mark GE, Aasbo JD, Joyner CA, Sharma S, Decena BF, Bolin ED, Weiss R, Burke MC, McClernon TR, Daoud EG, Gold MR. Anesthesia for subcutaneous implantable cardioverter defibrillator implantation: Perspectives from the clinical experience of a U.S. panel of physicians. PACE 2018; doi: 1111/pace. 13664
  • Theuns DAMJ, Brouwer TF, Jones PW, Allavatam V, Donnelley, S, Auricchio A, Knops RE, Burke MC. Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter defibrillator. Heart Rhythm 2018; 15(10): 1515-1522.
  • Quast ABE, Tjong FVY, Koop BE, Wilde AAM, Knops RE, Burke MC. Device orientation of a leadless pacemaker and subcutaneous implantable cardioverter-defibrillator in canine and human subjects and the effect on intrabody communication. Europace. 2018; 20(11): 1866-1871.
  • Frankel DS, Burke MC, Callans DJ, Stivland TM, Duffy E, Epstein AE, Impact of Body Mass Index on Safety and Efficacy of the Subcutaneous Implantable Cardioverter-Defibrillator. JACC Electrophysiology 2018, 4(5): 652-659
  • Amin AK, Gold MR, Burke MC, Knight BP, Rajjoub MR, Duffy E, Husby M, Stahl WK, Weiss R. Factors associated with high voltage impedance and subcutaneous implantable defibrillator ventricular fibrillation conversion success. Circ Arrhythmia and Electrophysiology 2019; 12(4): e006665. Doi: 10.1161/CIRCEP.118.006665
  • Brouwer TF, Burke MC, Knops RE. Letter regarding: Ventricular fibrillation conversion testing after implantation of a subcutaneous implantable cardioverter defibrillator: Report from the national cardiovascular data registry. Circulation 2018

FY2018

  • Essandoh MK, Mark GE, Aasbo JD, Joyner CA, Sharma S, Decena BF, Bolin ED, Weiss R, Burke MC, McClernon TR, Daoud EG, Gold MR. Anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: Perspectives from the clinical experience of a U.S. panel of physicians. Pacing Clin Electrophysiol. 2018 May 13. doi: 10.1111/pace.13364.
  • Frankel D, Burke MC, Callans D, Stivland T, Duffy E, Epstein A. (2018). Impact of Body Mass Index on Safety and Efficacy of the Subcutaneous Implantable Cardioverter-Defibrillator. JACC: Clinical Electrophysiology. 10.1016/j.jacep.2017.11.019.
  • Quast AF, Tjong F, Koop B, Wilde AAM, Knops RE, Burke MC. (2018). Device orientation of a leadless pacemaker and subcutaneous implantable cardioverter-defibrillator in canine and human subjects and the effect on intrabody communication. EP Europace. 10.1093/europace/euy019.
  • Theuns DAMJ, Brouwer TF, Jones P, Allavatam V, Donnelley S, Auricchio A, Knops RE, Burke MC, A Prospective, Blinded Evaluation Of A Novel Sensing Methodology Designed To Reduce Inappropriate Shocks By The Subcutaneous Implantable Defibrillator, Heart Rhythm (2018), doi: 10.1016/j.hrthm.2018.05.011
  • Tjong FVY, Brouwer TF, Koop B, Soltis B, Shuros A, Schmidt B, Swackhamer B, Quast AEB, Wilde AAM, Burke MC, Knops RE. Acute and 3-Month Performance of a Communicating Leadless Anti-tachycardia Pacemaker and Subcutaneous Implantable Defibrillator. JACC Clin Electrophysiol. 2017 Dec 26;3(13):1487-1498. doi: 10.1016/j.jacep.2017.04.002. Epub 2017 May 31.
  • Waxman AB, McElderry HT, Gomberg-Maitland M, Burke MC, Ross EL, Bersohn MM, Pangarkar SS, Tarver JH, Zwicke DL, Feldman JP, Chakinala MM, Frantz RP, Thompson GB, Torres F, Rauck RL, Clagg K, Durst L, Li P, Morris M, Southall KL, Peterson L, Bourge RC. Totally Implantable IV Treprostinil Therapy in Pulmonary Hypertension Assessment of the Implantation Procedure. Chest. 2017 Dec;152(6):1128-1134. doi: 10.1016/j.chest.2017.04.188. Epub 2017 Jun 3.
  • Gold MR, Aasbo JD, El-Chami MF, Niebauer M, Herre J, Prutkin JM, Knight BP, Kutalek S, Hsu K, Weiss R, Bass E, Husby M, Stivland TM, Burke MC. Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results. Heart Rhythm. 2017 Oct;14(10):1456-1463. doi: 10.1016/j.hrthm.2017.05.016. Epub 2017 May 11.